Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer

Completed · Phase 2

Conditions studied: Prostate Cancer

In brief

In men with prostate cancer who do not have evidence of spread to bone or other sites on computed axial tomography (CAT) scan/bone scan but are still at significant risk of failing treatment with surgery or radiation alone, a combination of chemotherapy and hormone therapy is being given for 6 months followed by surgery to remove the prostate.

Key facts

Study ID

NCT00108290

Run by

US Department of Veterans Affairs

Starts

2004-04-01

Expected to finish

2007-03-01

Last updated by the study team

2008-04-04

Who can join

Age: 18 and older, up to 80. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• High risk prostate cancer without evidence of bone metastasis.

Where it is running

• VA Maryland Health Care System — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.